Orexin Receptor Antagonist [EPC] - N0000191000
Pharmacologic Class Information
Pharmacologic Code | N0000191000 |
Pharmacologic Name | Orexin Receptor Antagonist |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Orexin Receptor Antagonist
The table contains 9 products whose active ingredient are classified under the same pharmacologic class Orexin Receptor Antagonist [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0006-0005 | Belsomra | Non-Proprietary Name: Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
0006-0033 | Belsomra | Non-Proprietary Name: Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
0006-0325 | Belsomra | Non-Proprietary Name: Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
0006-0335 | Belsomra | Non-Proprietary Name: Suvorexant | Tablet, Film Coated | Oral | Merck Sharp & Dohme Llc | ACTIVE | |
62856-405 | Dayvigo | Non-Proprietary Name: Lemborexant | Tablet, Film Coated | Oral | Eisai Inc. | ACTIVE | |
62856-410 | Dayvigo | Non-Proprietary Name: Lemborexant | Tablet, Film Coated | Oral | Eisai Inc. | ACTIVE | |
62856-455 | Dayvigo | Non-Proprietary Name: Lemborexant | Tablet, Film Coated | Oral | Eisai Inc. | ACTIVE | |
80491-7825 | Quviviq | Non-Proprietary Name: Daridorexant | Tablet, Film Coated | Oral | Idorsia Pharmaceuticals Ltd | ACTIVE | |
80491-7850 | Quviviq | Non-Proprietary Name: Daridorexant | Tablet, Film Coated | Oral | Idorsia Pharmaceuticals Ltd | ACTIVE |